IFNA1 and COVID-19: Taken together, our findings suggest a hypothesis that gene expression changes in mild COVID-19 stimulates an appropriate inflammatory response, involving mast cell activation that can drive downstream expression of cytokines and IFN mediators (Figures 4A, B).